The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2005

Filed:

Jun. 30, 2003
Applicants:

Rong-ming Lyu, Hsinchu, TW;

I-hong Pan, Hsinchu, TW;

Jir-mehng Lo, Hsinchu, TW;

Sue-fen Jiang, Hsinchu, TW;

Sheau-ni Su, Hsinchu, TW;

Nai-yun Hsu, Hsinchu, TW;

Shih Cheng Shen, Hsinchu, TW;

Hsin-chieh Wu, Hsinchu, TW;

Lain-tze Lee, Hsinchu, TW;

Yih-loong Lai, Yunghe, TW;

Jaw-ji Tsai, Taipei, TW;

Inventors:

Rong-Ming Lyu, Hsinchu, TW;

I-Hong Pan, Hsinchu, TW;

Jir-mehng Lo, Hsinchu, TW;

Sue-Fen Jiang, Hsinchu, TW;

Sheau-Ni Su, Hsinchu, TW;

Nai-Yun Hsu, Hsinchu, TW;

Shih Cheng Shen, Hsinchu, TW;

Hsin-Chieh Wu, Hsinchu, TW;

Lain-Tze Lee, Hsinchu, TW;

Yih-Loong Lai, Yunghe, TW;

Jaw-Ji Tsai, Taipei, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K035/78 ;
U.S. Cl.
CPC ...
Abstract

Pharmaceutical compositions for treating immunological disorders and the preparing method of the same are disclosed, which include alcohol extracts of(schw) Wolf, and. The compositions are manufactured by novel procedures consisting of decocting using specific concentration ranges of alcohol, filtering, regulating pH value, purifying, concentrating, proportionally mixing, and making a granule powder from lyophilized extract. This invention used both in vitro and in vivo assays to evaluate therapeutic effects of specific combination of herbal plant extracts. The combination of herbal extracts has been able to maximize the anti-inflammatory activity and regulate the secretion of cytokines such as eotaxin and IL-4. When the pharmaceutical composition of the present invention is used for asthma, it can relieve coughs, resist airway allergic inflammation reactions, improve the pulmonary functions, reduce allergen specific IgE in bloods, stabilize elasmatoblasts, and stop the attacks from asthma.


Find Patent Forward Citations

Loading…